SMALL MOLECULE THERAPEUTICS
Small Molecule Therapeutics operates as a drug discovery company. The company is headquartered in Monmouth Junction, New Jersey.
SMALL MOLECULE THERAPEUTICS
Address:
Monmouth Junction, New Jersey, United States
Country:
United States
Status:
Active
Contact:
(732) 274-2882
Similar Organizations
Felicitex Therapeutics
Felicitex Therapeutics is a drug discovery company
Stella Therapeutics
Stella Therapeutics, a privately held drug discovery company.
More informations about "Small Molecule Therapeutics"
Home | Structure Therapeutics
Feb 27, 2025 Our mission is to make important new medicines broadly accessible for patients through the advantages of oral small molecule therapeutics – including significant scalability – …See details»
Small Molecule Drug Discovery: Advancing Therapeutics
Mar 13, 2025 Refining small molecules into effective therapeutics requires a precise understanding of how they interact with biological targets. Structure-guided optimization …See details»
Into the Future with Next-generation Small Molecules
To small molecules are Amgen and Biogen. In January 2022, Amgen announced a collaboration with Arrakis Therapeutics focused on research into RNA degrader therapeutics against a …See details»
Home - RNA-Targeted Drug Discovery & Development Summit
With Remix Therapeutics joining forces with Roche and Daiichi Sankyo partnering with Depixus, there has been many valuable collaborations entering the RNA-targeting field accelerating …See details»
Pipeline - Drug Discovery - Psivant Therapeutics
We are designing small-molecule allosteric inhibitors to treat patients living with inflammatory and immunological disease. TNF Superfamily The TNF (Tumor Necrosis Factor Superfamily) …See details»
Small Molecule Drug Development | We Provide Small Molecule …
Medium Molecule vs. Small Molecule Drugs. Small molecule therapeutics range from iconic historical examples like penicillin and aspirin to modern-day pharmaceutical success stories …See details»
Small Molecule Therapeutics Scientific Interest Group
Jun 11, 2024 The Small Molecule Therapeutics SIG aims to have discussions, seminars and provide a platform for collaboration on interdisciplinary research that results in the identification …See details»
News | Skyhawk Therapeutics
Mar 25, 2024 Skyhawk's proprietary platform revolutionizes disease treatment by developing small molecule therapeutics that modify RNA expression. March 17, 2025. Skyhawk …See details»
Small molecules in targeted cancer therapy: advances, challenges, …
May 31, 2021 Despite great progress, small-molecule targeted anti-cancer drugs still face many challenges, such as a low response rate and drug resistance. To better promote the …See details»
OMass Unveils Rich Drug Discovery Pipeline Targeting Intractable …
Oxford, United Kingdom – 4 November 2021 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems, …See details»
Ono Enters into Drug Discovery Collaboration Agreement with …
Dec 3, 2024 Osaka, Japan and Montreal, Canada, December 3, 2024 - Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that it has …See details»
Small molecules - AstraZeneca
Small molecule drugs have been the mainstay of the pharmaceutical industry for nearly a century. Defined as any organic compound with low molecular weight, small molecule drugs have …See details»
Evonik partners with ST Pharm to increase its offerings …
Jan 8, 2025 We look forward to supporting our customers in developing the nucleic-acid therapeutics of the future,” said Yann d'Hervé, Head of the Health Care business line. ST Pharm is a contract development and manufacturing …See details»
Small molecules and their impact in drug discovery: A perspective …
Jun 1, 2022 Today, a combination of mostly small molecules from several drug classes are used in antiretroviral therapy, effectively reducing the viral load to a minimum and enabling a near …See details»
Small Molecule Drug Discovery: Key Trends And Growth
This preference is evident in diverse therapeutic segments, where small molecule therapeutics are becoming the standard in treating complex conditions. Moreover, with the expiration of …See details»
Discovery of small molecule cancer drugs: Successes, challenges …
Abstract. The discovery and development of small molecule cancer drugs has been revolutionised over the last decade. Most notably, we have moved from a one‐size‐fits‐all approach that …See details»
Designing small molecules for therapeutic success: A …
Feb 1, 2022 Successful small-molecule drug design requires a molecular target with inherent therapeutic potential and a molecule with the right properties to unlock its potential. Present …See details»
Skyhawk Therapeutics Presents at Huntington's Disease Youth ...
Mar 15, 2025 Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington's Disease to members of the Huntington's Disease Youth …See details»
Small Molecule CMO/CDMO Market 2025 - Opportunities & Share
A small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) is an entity that provides services to other companies in …See details»
FDA-Approved Small Molecules in 2022: Clinical Uses and Their …
Synthesis of abrocitinib (19) [].2.3. Mitapivat. Approved in February 2022 (17 February 2022) and developed by Agios Pharmaceuticals, mitapivat (25, brand name Pyrukynd ®) was approved …See details»